2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Adenocarcinoma
Adenocarcinoma is a type of cancer that originates in glandular tissue, which lines organs and forms the secretory portions of glands. It commonly affects organs like the lungs, colon, prostate, pancreas, and breast. Research in adenocarcinoma focuses on understanding genetic mutations and molecular pathways that drive its development and progression. Advances in genomic sequencing have identified key mutations, such as those in the KRAS, EGFR, and BRAF genes, which are pivotal in personalized medicine approaches. Current studies also explore the tumor microenvironment and its role in cancer growth and metastasis. Novel treatments, including targeted therapies and immunotherapies, are being developed and tested in clinical trials, aiming to improve survival rates and quality of life for patients with adenocarcinoma.
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Liu Ying
Shanghai University, China
Ratan Kumar Sarkar
Independent Researcher, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Shilpa S Dhar, UT MD Anderson Cancer Center, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada